InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Agenus stock is down on Thursday after the company provided AGEN investors with an update on a Phase 2 clinical trial meeting.
The post Why Is Agenus (AGEN) Stock Down 55% Today? appeared first on InvestorPlace.
More From InvestorPlace